Comparison of steroid substrates and inhibitors of P-glycoprotein by 3D-QSAR analysis

Steroid derivatives show a complex interaction with P-glycoprotein (Pgp). To determine the essential structural requirements of a series of structurally related and functionally diverse steroids for Pgp-mediated transport or inhibition, a three-dimensional quantitative structure activity relationship study was performed by comparative similarity index analysis modeling. Twelve models have been explored to well correlate the physiochemical features with their biological functions with Pgp on basis of substrate and inhibitor datasets, in which the best predictive model for substrate gave cross-validated q(2) = 0.720, non-cross-validated r(2) = 0.998, standard error of estimate SEE = 0.012, F = 257.955, and the best predictive model for inhibitor gave q(2) = 0.536, r(2) = 0.950, SEE = 1.761 and F = 45.800. The predictive ability of all models was validated by a set of compounds that were not included in the training set. The physiochemical similarities and differences of steroids as Pgp substrate and inhibitor, respectively, were analyzed to be helpful in developing new steroid-like compounds. (C) 2004 Elsevier B.V. All rights reserved.

[1]  G. Fleming,et al.  Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein , 2004, Cancer Chemotherapy and Pharmacology.

[2]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[3]  Gerhard Klebe,et al.  Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries , 1999, J. Comput. Aided Mol. Des..

[4]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[5]  M Karplus,et al.  Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications. , 1997, Journal of medicinal chemistry.

[6]  T. Fojo,et al.  Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells , 1996 .

[7]  M. Wehling.  Specific, nongenomic actions of steroid hormones. , 1997, Annual review of physiology.

[8]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Gasteiger,et al.  Calculation of the Charge Distribution in Conjugated Systems by a Quantification of the Resonance Concept , 1985 .

[10]  P. Geladi.  Notes on the history and nature of partial least squares (PLS) modelling , 1988 .

[11]  Peter W. Swaan,et al.  Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids , 2003, Pharmaceutical Research.

[12]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Housman,et al.  Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus , 1990, Molecular reproduction and development.

[14]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[15]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[16]  K. Audus,et al.  Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. , 2001, International journal of pharmaceutics.

[17]  S. Bourgeois,et al.  Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function. , 1997, Cancer research.

[18]  E. Lien,et al.  Structure–activity relationship: analyses of p‐glycoprotein substrates and inhibitors , 2003, Journal of clinical pharmacy and therapeutics.

[19]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[20]  R. Béliveau,et al.  Dexamethasone modulation of multidrug transporters in normal tissues , 1999, FEBS letters.

[21]  Robert,et al.  Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. , 1989, The Journal of biological chemistry.

[22]  H. Rosenberg,et al.  Intronic Enhancer Activity of the Eosinophil-derived Neurotoxin (RNS2) and Eosinophil Cationic Protein (RNS3) Genes Is Mediated by an NFAT-1 Consensus Binding Sequence* , 1997, The Journal of Biological Chemistry.

[23]  S. Horwitz,et al.  P‐glycoprotein transports corticosterone and is photoaffinity‐labeled by the steroid , 1992, International journal of cancer.

[24]  S. Bourgeois,et al.  Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. , 1993, Molecular endocrinology.

[25]  B. Lacarelle,et al.  Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals. , 1998, Biochemical and biophysical research communications.

[26]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.